Encompass Health Corporation (EHC) vs Exelixis, Inc. (EXEL)
A side-by-side comparison of Encompass Health Corporation and Exelixis, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 11, 2026. Differences are shown without an overall score or investment verdict.
EHC
Encompass Health Corporation
$121.71HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
EXEL
Exelixis, Inc.
$56.12HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
Total return — EHC vs EXEL
growth of $100 · dividends reinvested · last 10yEHC +324.8% (+15.6%/yr)EXEL +323.8% (+15.5%/yr)EHC compounded faster over this window
EHC EXEL
EHC vs EXEL: by the numbers
- •EXEL is the larger company ($14.11B vs $12.07B market cap).
- •EXEL trades at the lower trailing earnings multiple (17.59 vs 19.82 P/E), one valuation lens rather than an overall verdict.
- •EXEL converts more revenue to profit (35.33% vs 10.01% net margin).
- •EXEL grew revenue faster over the past five years (16.06% vs 4.81% CAGR).
- •EHC pays a dividend (0.63% yield), while EXEL has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | EHC | EXEL |
|---|---|---|
| P/E ratio | 19.82 | 17.59 |
| Forward P/E | 19.91 | 15.98 |
| P/S ratio | 1.95 | 5.79 |
| P/B ratio | 4.65 | 7.65 |
| EV / EBITDA | 10.12 | 13.99 |
| FCF yield | 3.42% | 8.34% |
Profitability
| Metric | EHC | EXEL |
|---|---|---|
| Gross margin | 95.71% | 96.48% |
| Operating margin | 18.00% | 39.88% |
| Net margin | 10.01% | 35.33% |
| ROE | 23.91% | 46.68% |
| ROIC | 13.42% | 37.87% |
Dividends
| Metric | EHC | EXEL |
|---|---|---|
| Dividend yield | 0.63% | N/A |
| Payout ratio | 12.38% | N/A |
Growth (annualized)
| Metric | EHC | EXEL |
|---|---|---|
| Revenue CAGR (5Y) | 4.81% | 16.06% |
| EPS CAGR (5Y) | 14.39% | 51.51% |
| FCF CAGR (5Y) | 0.28% | 40.17% |
| Total return CAGR (5Y) | 15.18% | 23.54% |
Frequently asked
- Which has the lower trailing P/E, EHC or EXEL?
- EXEL has the lower trailing P/E: EHC trades at 19.82 and EXEL at 17.59. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, EHC or EXEL?
- Over the past five years, EXEL grew revenue faster — EHC at a 4.81% CAGR versus EXEL at 16.06%.
- Does EHC or EXEL pay a bigger dividend?
- EHC pays a dividend (0.63% yield), while EXEL has no payments in the available dividend history.
- Is EHC or EXEL more profitable?
- EXEL runs the higher net margin — EHC at 10.01% versus EXEL at 35.33%.
- How have EHC and EXEL total returns compared?
- Over the past 10 years, EHC delivered 15.73% and EXEL delivered 16.97% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Encompass Health P/E ratioExelixis P/E ratioEncompass Health dividend yieldEncompass Health ROEExelixis ROEEncompass Health operating marginExelixis operating marginEncompass Health revenue growthExelixis revenue growthEncompass Health free cash flowExelixis free cash flow
Encompass Health & Exelixis appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 11, 2026.